Stock Events

Avisa Diagnostics 

$0
1
+$0+0% Thursday 13:34

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
166
Avg. Volume
400
Mkt Cap
268,055
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

30SepConfirmed
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
-0.03
-0.02
-0.01
0
Expected EPS
0
Actual EPS
-0.0015

People Also Follow

This list is based on the watchlists of people on Stock Events who follow FOGCF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Packaged Software
Technology Services
Avisa Diagnostics Inc. operates a clinical-stage medical device company. It is developing the Avisa BreathTest, a novel drug/device biomarker technology platform that enables the ultra-rapid detection of virulent bacterial pathogens, detecting and monitoring bacterial load after the patient inhales or ingests its proprietary drug substrates. The company offers clinical proof-of-concept through trials in cystic fibrosis, tuberculosis, and communityacquired pneumonia. It focuses on pivotal trials in Post-COVID-19 bronchiectasis and ventilator-associated pneumonia. Avisa Diagnostics Inc. is based in Santa Fe, New Mexico.
Show more...
CEO
Country
CA
ISIN
CA05380J1075
WKN
000A3CMVD

Listings